Velı Berk

1.5k total citations
53 papers, 1.1k citations indexed

About

Velı Berk is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Velı Berk has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Velı Berk's work include Colorectal Cancer Treatments and Studies (20 papers), Cancer Treatment and Pharmacology (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Velı Berk is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Cancer Treatment and Pharmacology (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Velı Berk collaborates with scholars based in Türkiye, Norway and Hong Kong. Velı Berk's co-authors include Halıt Karaca, Metin Özkan, Mahmut Akpek, Nihat Kalay, Ali Ergin, Mevlüde İnanç, Oktay Bozkurt, Ersin Özaslan, Ayşe Ocak Duran and Mustafa Dikilitaş and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Heart Failure and International Journal of Cardiology.

In The Last Decade

Velı Berk

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Velı Berk Türkiye	17	650	381	361	150	147	53	1.1k
Sakti Chakrabarti United States	16	603 0.9×	182 0.5×	215 0.6×	164 1.1×	210 1.4×	92	1.0k
Clara Klerk Netherlands	9	196 0.3×	218 0.6×	134 0.4×	245 1.6×	102 0.7×	18	1.1k
Aurélien Lambert France	15	392 0.6×	224 0.6×	162 0.4×	137 0.9×	155 1.1×	69	814
Ralph J. Doerr United States	18	283 0.4×	83 0.2×	302 0.8×	126 0.8×	64 0.4×	35	808
Nikolaos Gouvas Greece	19	858 1.3×	204 0.5×	278 0.8×	119 0.8×	91 0.6×	43	1.3k
Yasushi Matsushita Japan	15	264 0.4×	149 0.4×	439 1.2×	220 1.5×	76 0.5×	63	969
Brian Bird Ireland	11	279 0.4×	150 0.4×	106 0.3×	65 0.4×	53 0.4×	37	536
Ugo Pace Italy	18	646 1.0×	72 0.2×	468 1.3×	203 1.4×	133 0.9×	49	1.3k
Raffaella Palumbo Italy	20	560 0.9×	42 0.1×	474 1.3×	313 2.1×	160 1.1×	59	1.1k
Yosuke Morodomi Japan	22	731 1.1×	45 0.1×	684 1.9×	264 1.8×	141 1.0×	71	1.4k

Countries citing papers authored by Velı Berk

Since Specialization

Citations

This map shows the geographic impact of Velı Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Velı Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Velı Berk more than expected).

Fields of papers citing papers by Velı Berk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Velı Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Velı Berk. The network helps show where Velı Berk may publish in the future.

Co-authorship network of co-authors of Velı Berk

This figure shows the co-authorship network connecting the top 25 collaborators of Velı Berk. A scholar is included among the top collaborators of Velı Berk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Velı Berk. Velı Berk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Kaplan, Zeynep Oruç, Mahmut Gümüş, et al.. (2020). The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.. PubMed. 24(3). 1081–1086. 1 indexed citations

Özaslan, Ersin, Velı Berk, Oktay Bozkurt, et al.. (2015). Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients. Asian Pacific Journal of Cancer Prevention. 16(7). 3015–3021. 20 indexed citations

Bozkurt, Oktay, Serkan Şenol, Ayşe Ocak Duran, et al.. (2015). Primary Pleomorphic Rhabdomyosarcoma of Thyroid Gland in an Adult Patient: A Case Report. Eurasian Journal of Medicine. 48(1). 69–72. 6 indexed citations

Şendur, Mehmet Alı Nahıt, Nuriye Özdemir, Sercan Aksoy, et al.. (2015). Efficacy of Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel versus Conventional Dose Doxorubicin, Cyclophosphamide Followed by Paclitaxel or Docetaxel in Patients with Node-Positive Breast Cancer. Asian Pacific Journal of Cancer Prevention. 16(4). 1471–1477. 3 indexed citations

Bozkurt, Oktay, Velı Berk, Kaplan Ma, et al.. (2014). Lack of Prognostic Value of Mean Corpuscular Volume with Capecitabine Therapy in Metastatic Breast Cancer. Asian Pacific Journal of Cancer Prevention. 15(6). 2501–2504. 5 indexed citations

İnanç, Mevlüde, Ayşe Ocak Duran, Velı Berk, et al.. (2014). Haematologic Parameters in Metastatic Colorectal Cancer Patients Treated with Capecitabine Combination Therapy. Asian Pacific Journal of Cancer Prevention. 15(1). 253–256. 14 indexed citations

Bozkurt, Oktay, Mevlüde İnanç, Velı Berk, et al.. (2014). Clinicopathological Characteristics and Prognosis of Patients According to Recurrence Time After Curative Resection for Colorectal Cancer. Asian Pacific Journal of Cancer Prevention. 15(21). 9277–9281. 20 indexed citations

Karaca, Halıt, Oktay Bozkurt, Ersin Özaslan, et al.. (2014). Positive Effects of Oral β-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy. Asian Pacific Journal of Cancer Prevention. 15(8). 3641–3644. 17 indexed citations

Duran, Ayşe Ocak, Mevlüde İnanç, Velı Berk, et al.. (2014). Albumin-globulin Ratio for Prediction of Long-term Mortality in Lung Adenocarcinoma Patients. Asian Pacific Journal of Cancer Prevention. 15(15). 6449–6453. 54 indexed citations

10.

Mutlu, Hasan, Abdullah Büyükçelik, Halıt Karaca, et al.. (2013). Secondline Chemotherapy Versus Best Supportive Care in Patient with Malignant Pleural Mesothelioma: A Retrospective Study. Asian Pacific Journal of Cancer Prevention. 14(6). 3887–3889. 5 indexed citations

11.

İnanç, Mevlüde, Metin Özkan, Halıt Karaca, et al.. (2013). Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer. Medical Oncology. 31(1). 801–801. 51 indexed citations

12.

Berk, Velı, Kaplan Ma, Süleyman Buyukberber, et al.. (2013). Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention. 14(12). 7367–7369. 27 indexed citations

13.

Ustaalıoğlu, Bala Başak Öven, Olçun Ümit Ünal, Nedim Turan, et al.. (2013). Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences. Asian Pacific Journal of Cancer Prevention. 14(11). 6287–6292. 11 indexed citations

14.

Çetin, Bülent, Mustafa Beneklı, Berna Öksüzoğlu, et al.. (2012). Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience. Onkologie. 35(12). 740–745. 16 indexed citations

15.

Yıldız, Ramazan, Mustafa Beneklı, Metin Özkan, et al.. (2012). Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer. Journal of Cancer Research and Clinical Oncology. 138(11). 1845–1852. 4 indexed citations

16.

Turan, Nedim, Mustafa Beneklı, Doğan Koca, et al.. (2012). Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer. Oncology. 84(1). 14–21. 18 indexed citations

17.

Çetin, Bülent, Kaplan Ma, Velı Berk, et al.. (2012). Prognostic Factors for Overall Survival in Patients With Metastatic Colorectal Carcinoma Treated With Vascular Endothelial Growth Factor-Targeting Agents. Asian Pacific Journal of Cancer Prevention. 13(3). 1059–1063. 23 indexed citations

18.

Berk, Velı, Hayati Demiraslan, Halıt Karaca, et al.. (2012). Moxifloxacin-associated neutropenia. Scandinavian Journal of Infectious Diseases. 45(5). 415–416. 4 indexed citations

19.

Kaya, Ali, Uğur Çoşkun, Metin Özkan, et al.. (2012). Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy. Onkologie. 35(10). 576–580. 5 indexed citations

20.

Arslan, Ülkü Yalçıntaş, Berna Öksüzoğlu, Nuriye Özdemir, et al.. (2011). Outcome of non-metastatic male breast cancer: 118 patients. Medical Oncology. 29(2). 554–560. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact